MeSH D003267 - contraception
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012099:Reproductive techniques
0 Companies
0 Drugs
Success rate
D003267:Â
Contraception
D000073516:Contraceptive effectiveness
0 Companies
0 Drugs
Success rate
D000075523:Long-acting reversible contraception
0 Companies
0 Drugs
Success rate
D000080282:Hormonal contraception
0 Companies
0 Drugs
Success rate
D003076:Coitus interruptus
0 Companies
0 Drugs
Success rate
D013245:Reproductive sterilization
0 Companies
0 Drugs
Success rate
D034445:Ovulation inhibition
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Gedeon Richter | Ethinyl estradiol, Norelgestromin | Evra |  | 2002-08-22 |  |  |
| Organon | Estradiol, Nomegestrol | Ioa |  | 2011-11-16 |  |  |
| Theramex | Estradiol, Nomegestrol | Zoely |  | 2011-07-26 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
74%20/27
Phase 2
54%20/37
Phase 3
76%25/33
Approved: 6Overall Success rate: 30%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use